Cargando…
Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases
In vivo exploration of activated microglia in neurodegenerative diseases is achievable by Positron Emission Tomography (PET) imaging, using dedicated radiopharmaceuticals targeting the translocator protein-18 kDa (TSPO). In this review, we emphasized the major advances made over the last 20 years, t...
Autores principales: | Dupont, Anne-Claire, Largeau, Bérenger, Santiago Ribeiro, Maria Joao, Guilloteau, Denis, Tronel, Claire, Arlicot, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412369/ https://www.ncbi.nlm.nih.gov/pubmed/28387722 http://dx.doi.org/10.3390/ijms18040785 |
Ejemplares similares
-
TSPO PET Imaging: From Microglial Activation to Peripheral Sterile Inflammatory Diseases?
por: Largeau, Bérenger, et al.
Publicado: (2017) -
Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations
por: Tronel, Claire, et al.
Publicado: (2017) -
The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases
por: Dupont, Anne-Claire, et al.
Publicado: (2018) -
Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases
por: Ching, Alex Sik Chung, et al.
Publicado: (2011) -
18 kDa Translocator Protein TSPO Is a Mediator of
Astrocyte Reactivity
por: Tournier, Benjamin B., et al.
Publicado: (2023)